Paul Bunn
10Patents
4h-index
16Co-inventors
53Inventor score
Filing activity: Jul 20, 1993 → Jul 5, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5411730A | Magnetic microparticles | Emerging Cross-Sectional Technologies | 108 | Expired |
| US6048550A | Hydrophilic microparticles and methods to prepare same | Human Necessities | 62 | Expired |
| US5980935A | Cationic lipids and methods of use therefor | Human Necessities | 15 | Expired |
| US6388054B1 | Anti-cancer compounds | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7071168B2 | Anti-cancer compounds and methods related thereto | Emerging Cross-Sectional Technologies | 3 | Expired |
| US8017321B2 | Gefitinib sensitivity-related gene expression and products and methods related thereto | Chemistry; Metallurgy | 1 | Expired |
| US7427496B2 | Anti-cancer compounds | Human Necessities | 1 | Expired |
| US8575170B2 | Flurbiprofen analogs and methods of use in treating cancer | Human Necessities | 1 | Active |
| US7858349B2 | Anti-cancer compounds | Human Necessities | 0 | Active |
| US9434994B2 | Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by non-small cell lung cancer patients | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.